Pharma Journalist - Page 698 of 834 -

Axcynsis Receives FDA Clearance for IND of AT03-65, CLDN6-Targeting ADC

FDA Approves Lilly’s Omvoh for Crohn’s Disease, Expanding IBD Treatment Options

AbbVie and Simcere Zaiming Partner to Develop Trispecific Antibody for Multiple Myeloma

FDA concedes Glooko’s Mobile Insulin Dosing System

Bristol-Myers Squibb and Nektar Therapeutics collaborate commercially for NKTR-214

OTTR partners Hemasoft to facilitate transfusion medicine

IRX Therapeutics commences Phase 2 Clinical Trial for CIN3 or VIN3 women

Neurocrine Biosciences files NDA for opicapone for Parkinson’s disease

Sandoz asserts FDA’s approval for initiation of Glatopa

FDA clearance sought for Roche’s Factor II and Factor V test on cobas 4800 system

FDA sanctions breakthrough treatment for specific kind of Prostate Cancer

J&J Pharmaceuticals announce approval of ERLEADA by FDA for NM-CRPC patients

Mallinckrodt affirms enlisting of first patient for ExpressGraft C9T1 Phase 1 Study